Health

Brand-name and generic drug makers are squaring off for a costly political battle -- and consumers may pick up the tab.

| Mon Mar. 5, 2001 1:00 AM PST
Get Mother Jones by Email - Free. Like what you're reading? Get the best of MoJo three times a week.